Shelley Jones-Dillon, MD
Emergency Medicine · Newark, NJNPI 1174576870
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AstraZeneca at 40.5% of the total. Reporting peaked in 2023 at $541 and has fallen 77.7% since, to $121 in 2025. Among emergency medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $62.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$478
- AbbVie$207
- Boehringer Ingelheim$125
- Bioxcel Therapeutics, Inc.$125
- Gilead$122
- Johnson & Johnson$99
- plus $25 from 1 others
What the payments were for
- Food & beverage$1,180100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $478 |
| AbbVie | 6 | $207 |
| Boehringer Ingelheim | 1 | $125 |
| Bioxcel Therapeutics, Inc. | 2 | $125 |
| Gilead | 1 | $122 |
| Johnson & Johnson | 2 | $99 |
| CSL Behring | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,180 in reported general payments places this provider in the 90th percentile of 1,505 emergency medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 12 | $20 |
| Prednisone | 12 | $17 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Newark
- Aislinn BlackNewark$11K
- Ethan CowanNewark$9K
- Nicole MaguireNewark$3K
- Michael GouldSomerville$2.8M
- Kenneth MinettParsippany$797K
- Marc MilanoBerkeley Heights$392K
- Gerardo ChiricoloToms River$161K
- Hardik SoniDenville$159K
- Lindsay van PeltPompton Plains$146K
- Joseph TestaWayne$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.